+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
KILITCH

Kilitch Drugs(I) Share Price

 

 

Kilitch Drugs(I) live price: ₹175.34. It opened at ₹179 vs previous close ₹180; intraday high/low: ₹180/₹171. The 50 & 200 DMA stand at ₹178.30/₹172.54.

Kilitch Drugs(I) Performance

  • Today's Low
  • ₹171
  • Today's High
  • ₹180
  • 52 Week Low
  • ₹117
  • 52 Week High
  • ₹250
  • Open Price₹179
  • Previous Close₹180
  • Volume23,278
  • 50 DMA₹178.30
  • 100 DMA₹172.63
  • 200 DMA₹172.54

Kilitch Drugs(I) Chart

Investment Returns

  • Over 1 Month -7.24%
  • Over 3 Month + 40.62%
  • Over 6 Month + 2.71%
  • Over 1 Year -22.82%

Smart Investing Starts Here Start SIP with Kilitch Drugs(I) for Steady Growth!

Invest Now

Kilitch Drugs(I) Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 20.3
  • PEG Ratio
  • 1.4
  • Market Cap Cr
  • 613
  • P/B Ratio
  • 2.2
  • Average True Range
  • 9.78
  • EPS
  • 8.63
  • Dividend Yield
  • 0
  • MACD Signal
  • 3.24
  • RSI
  • 42.74
  • MFI
  • 44.01

Latest Stock News Updates

This small-cap pharma firm is eyeing a pie of the growing weight-loss drug market

Mumbai-based Kilitch Drugs Ltd plans to enter biosimilars and oral solids, including diabetic and weight-loss tablets, and is expanding its manufacturing capacity with a new facility in Khopoli, Maharashtra

US FDA Issues Warning Letter To Kilitch Healthcare For Navi-Mumbai Plant

The warning letter summarises significant violations of current good manufacturing practice regulations for finished pharmaceuticals at the Navi-Mumbai plant, which produces finished pharmaceuticals.

Kilitch Drugs Standalone December 2023 Net Sales at Rs 29.77 crore, up 4.43% Y-o-Y

Kilitch Drugs(I) Financials

Kilitch Drugs(I) Technicals

EMA & SMA

Current Price
₹175.34
-4.37 (-2.43%)
pointer
  • Bearish Moving Average 11
  • Bullish Moving Average 5
  • 20 Day
  • ₹184.80
  • 50 Day
  • ₹178.30
  • 100 Day
  • ₹172.60
  • 200 Day
  • ₹172.50

Resistance and Support

175.4 Pivot Speed
  • R3 188.33
  • R2 184.04
  • R1 179.69
  • S1 171.05
  • S2 166.76
  • S3 162.41

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Kilitch Drugs India has an operating revenue of Rs. 235.47 Cr. on a trailing 12-month basis. An annual revenue growth of 18% is outstanding, Pre-tax margin of 16% is great, ROE of 10% is good. The company has a reasonable debt to equity of 21%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 5% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 84 which is a GOOD score indicating consistency in earnings, a RS Rating of 75 which is FAIR indicating the recent price performance, Buyer Demand at A which is evident from recent demand for the stock, Group Rank of 48 indicates it belongs to a fair industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Kilitch Drugs(I) Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-15 Audited Results
2026-02-11 Quarterly Results & Bonus issue
2025-11-13 Quarterly Results
2025-08-13 Quarterly Results
2025-07-02 Others Inter-alia, to consider 1. Fund Raising by way of issue of equity shares of face value of 10/-each through Rights Issue. 2. Deployment of the proceeds of the Right Issue. 3. Other business matters. issue of equity shares of Rs. 10/- in the ratio of 2:23 @ premium of Rs. 347/-.
Date Purpose Remarks
2026-03-24 Bonus Rs.0.00 issue of equity shares in the ratio of 1:1 of Rs. 10/-.

Kilitch Drugs(I) Shareholding Pattern

63.77%
0%
0%
0.12%
0%
29.64%
6.47%

Kilitch Drugs(I) FAQs

Kilitch Drugs(I) share price is ₹175 As on 15 July, 2026 | 06:31

The Market Cap of Kilitch Drugs(I) is ₹613 Cr As on 15 July, 2026 | 06:31

The P/E ratio of Kilitch Drugs(I) is 20.3 As on 15 July, 2026 | 06:31

The PB ratio of Kilitch Drugs(I) is 2.2 As on 15 July, 2026 | 06:31

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23